SHENZHEN, China, Feb. 28, 2023 /Xinhua-AsiaNet/– The 16 Co-operation Measures for the Development of the Qianhai Shenzhen-Hong Kong Intellectual Property and Innovation Hub (16 Measures), jointly promulgated by the Authority of Qianhai Shenzhen-Hong Kong Modern Service Industry Cooperation Zone of Shenzhen Municipality
FUZHOU, China, Feb. 28, 2023 /Xinhua-AsiaNet/– Recently, the promotional video of Fuzhou city of Fujian Province, titled “What You Did Not Know about Fuzhou — Jasmine Tea”, was released through overseas social media accounts including “Oriental.Paris”, “Discover Fujian” and “Discover Fuzhou”, inviting
SHENZHEN, China, Feb. 28, 2023 /Xinhua-AsiaNet/– Qianhai now appears to be the first stop for Hong Kong-invested financial institutions to enter the mainland, and Qianhai has made another breakthrough in financial innovation. On February 23, the Opinions on Providing Financial Support for
Global Service Providers Utilizing Synchronoss Platforms to Deliver Value-Added Services to Tens of Millions of Subscribers BRIDGEWATER, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in cloud, messaging and
NEW YORK, Feb. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fate Therapeutics, Inc. (NASDAQ: FATE) between April 2, 2020 and January 5, 2023, both dates inclusive (the “Class Period”).
NEW YORK, Feb. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the stock of Bioventus Inc. (NASDAQ: BVS): (i) pursuant and/or traceable to the offering documents issued in connection with the Company’s
NEW YORK, Feb. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BioLineRx Ltd. (NASDAQ: BLRX) between February 23, 2021 and September 19, 2022, both dates inclusive (the “Class Period”),